Global office locator

From early planning to execution, ICON supports your obesity trials with strategic insight, operational excellence, and proven infrastructure. See how in our case studies. https://ow.ly/kStl50WY1c1

Why do stability studies matter in early drug development? From shelf-life determination to regulatory readiness, a well-designed stability program ensures your drug product remains safe, effective, and reliable. Learn...

In honour of World Heart Day, ICON is spotlighting the importance of cardiovascular studies, which are critical to protecting and advancing heart health. In our blog, learn how CV studies can use digital health technolog...

In just two days Andrew Roche, Senior Director of Scientific Affairs, will present at the Biomarkers & Precision Medicine conference. His session, “Key considerations for high-quality data generation in global clinical ...

Discover how ICON helped a sponsor overcome recruitment challenges in a competitive, technically complex environment leveraging targeted site selection and operational precision to exceed enrolment goals and safeguard co...

The therapeutic landscape for obesity is changing rapidly. Endpoints focused only on weight loss are no longer enough. Regulators now expect measures that capture the entire patient experience. Join ICON experts on Oct...

We are pleased to share that ICON has been recognised for the second consecutive year by the Mamá Godín initiative in Mexico. This recognition reflects our commitment to supporting working parents and caregivers through ...

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

Ensuring that a cardiovascular outcomes trial is conducted consistently across all trial sites, particularly international ones, helps minimise confounding variables and supports the validity of the trial’s findings. I...

As clinical trials grow more complex, programming strategies must evolve. R, an open-source programming language for statistical computing, is enabling greater efficiency, higher quality outputs and faster data driven de...

As global pressures reshape the pharmaceutical and biotech landscape, sponsors are re-evaluating their outsourcing strategies. In this article, Maria DiPietro shares insights from ICON’s recent survey of industry stakeho...

ICON is advancing site and patient engagement through innovation. At the SCRS Global Site Solutions Summit, discover how Accellacare and FIRECREST are delivering integrated site support and digital enablement to drive tr...